Synovics Pharmaceuticals, Inc. Stock

Equities

SYVC

US87163M1018

Pharmaceuticals

Market Closed - OTC Markets 14:10:02 2023-08-04 EDT 5-day change 1st Jan Change
0.0001 USD -.--% Intraday chart for Synovics Pharmaceuticals, Inc. -.--% -.--%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2007 23.47M 32.09M Sales 2008 25.96M 35.5M Capitalization 9.04M 12.36M
Net income 2007 -20M -27.35M Net income 2008 -4M -5.47M EV / Sales 2007 1.81 x
Net Debt 2007 18.79M 25.7M Net Debt 2008 6.49M 8.87M EV / Sales 2008 0.6 x
P/E ratio 2007
-0.73 x
P/E ratio 2008
-2.06 x
Employees 155
Yield 2007 *
-
Yield 2008
-
Free-Float 95.75%
More Fundamentals * Assessed data
Dynamic Chart
1 year
0.00
Extreme 0.0001
0.00
3 years
0.00
Extreme 0
0.00
5 years
0.00
Extreme 0
0.00
10 years
0.00
Extreme 0
0.01
More quotes
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW